Houston MD Grounded by DEA Over Medicare Ban and Prescription Woes
Published Date: 9/23/2025
Notice
Summary
Dr. Rachel Kientcha-Tita from Houston lost her DEA registration because she’s barred from Medicare, Medicaid, and other federal health programs. The DEA officially revoked her license and denied her renewal after a thorough review and hearing. This means she can’t legally prescribe controlled substances through federal programs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked and Denied
DEA Certificate of Registration No. FK0843462 for Rachel Kientcha‑Tita, M.D., is revoked and any pending renewal or modification is denied. The Order also denies any other pending application by Dr. Kientcha‑Tita for registration in Texas. This Order is effective October 23, 2025.
Fifteen‑Year Federal Exclusion (Medicare/Medicaid)
The U.S. Department of Health and Human Services, Office of Inspector General excluded Rachel Kientcha‑Tita, M.D., from Medicare, Medicaid, and all federal health care programs effective August 20, 2017, for a period of fifteen years (through August 20, 2032). Because of that exclusion, DEA found she has been and remains excluded and revoked and denied her DEA registration.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in